Thus, its overexpression is related to worse outcomes in patients with solid cancer.33 In this way, several studies revealed the contribution of miR- 214,34 miR-138,35 miR-30a,36 and miR-193a16 to the EMT process in BC cells by vimentin expression. The gene discussed is VIM; the disease is breast cancer.